Inhaled Steroids: First Line Treatment of Adult Asthma | Zendy

André Cartier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Inhaled Steroids: First Line Treatment of Adult Asthma

Author(s) -

André Cartier

Publication year - 1995

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/1995/170230

Subject(s) - medicine , asthma , budesonide , inhaled corticosteroids , inhalation , first line treatment , corticosteroid , b2 receptor , asthma exacerbations , anesthesia , intensive care medicine , chemotherapy , bradykinin , receptor

Corticosteroids are the most potent inhaled anti-inflammatory drugs for asthma treatment. This paper reviews the clinical evidence supporting the early use of inhaled steroids in asthma as a first line treatment. Inhaled steroids can probably alter the course of asthma, especially in mild asthmatics. Once they have been shown to improve control of asthma and even if the need for beta2-agonists is virtually nil, their use should be continued at low doses (ie, equivalent to 400 to 500 μg of budesonide or beclomethasone) for at least one year before attempting to reduce the dosage

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research